304840 — Peoplebio Balance Sheet
0.000.00%
- KR₩56bn
- KR₩58bn
- KR₩4bn
Annual balance sheet for Peoplebio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9,365 | 38,810 | 22,543 | 5,244 | 6,393 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 288 | 303 | 1,768 | 4,045 | 3,674 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10,099 | 40,145 | 29,341 | 14,810 | 17,076 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 384 | 2,289 | 3,672 | 3,550 | 2,454 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 10,655 | 51,348 | 42,316 | 27,580 | 27,075 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 507 | 29,266 | 32,836 | 3,533 | 16,554 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,827 | 34,432 | 38,237 | 8,409 | 18,681 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 8,828 | 16,915 | 4,079 | 19,171 | 8,393 |
Total Liabilities & Shareholders' Equity | 10,655 | 51,348 | 42,316 | 27,580 | 27,075 |
Total Common Shares Outstanding |